Weiss T - Search Results

1

Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.

Schmassmann P, Roux J, Buck A, Tatari N, Hogan S, Wang J, Rodrigues Mantuano N, Wieboldt R, Lee S, Snijder B, Kaymak D, Martins TA, Ritz MF, Shekarian T, McDaid M, Weller M, Weiss T, Läubli H, Hutter G. Schmassmann P, et al. Among authors: weiss t. Sci Transl Med. 2023 Jul 19;15(705):eadf5302. doi: 10.1126/scitranslmed.adf5302. Epub 2023 Jul 19. Sci Transl Med. 2023. PMID: 37467314

2

Addition of lomustine for bevacizumab-refractory recurrent glioblastoma.

Tonder M, Eisele G, Weiss T, Hofer S, Seystahl K, Valavanis A, Stupp R, Weller M, Roth P. Tonder M, et al. Among authors: weiss t. Acta Oncol. 2014 Oct;53(10):1436-40. doi: 10.3109/0284186X.2014.920960. Epub 2014 May 26. Acta Oncol. 2014. PMID: 24862539 Free article. No abstract available.

3

Immunotherapy for glioblastoma: concepts and challenges.

Weiss T, Weller M, Roth P. Weiss T, et al. Curr Opin Neurol. 2015 Dec;28(6):639-46. doi: 10.1097/WCO.0000000000000249. Curr Opin Neurol. 2015. PMID: 26402401 Free article. Review.

4

Immunological effects of chemotherapy and radiotherapy against brain tumors.

Weiss T, Weller M, Roth P. Weiss T, et al. Expert Rev Anticancer Ther. 2016 Oct;16(10):1087-94. doi: 10.1080/14737140.2016.1229600. Epub 2016 Sep 6. Expert Rev Anticancer Ther. 2016. PMID: 27598516 Free article. Review.

5

NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma.

Weiss T, Schneider H, Silginer M, Steinle A, Pruschy M, Polić B, Weller M, Roth P. Weiss T, et al. Clin Cancer Res. 2018 Feb 15;24(4):882-895. doi: 10.1158/1078-0432.CCR-17-1766. Epub 2017 Nov 21. Clin Cancer Res. 2018. PMID: 29162646 Free article.

6

NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma.

Weiss T, Weller M, Guckenberger M, Sentman CL, Roth P. Weiss T, et al. Cancer Res. 2018 Feb 15;78(4):1031-1043. doi: 10.1158/0008-5472.CAN-17-1788. Epub 2017 Dec 8. Cancer Res. 2018. PMID: 29222400 Free article.

7

Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.

Papa E, Weller M, Weiss T, Ventura E, Burghardt I, Szabó E. Papa E, et al. Among authors: weiss t. Cell Death Dis. 2017 Dec 13;8(12):3210. doi: 10.1038/s41419-017-0051-2. Cell Death Dis. 2017. PMID: 29238047 Free PMC article.

8

Transcriptional control of O⁶ -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma.

Happold C, Stojcheva N, Silginer M, Weiss T, Roth P, Reifenberger G, Weller M. Happold C, et al. Among authors: weiss t. J Neurochem. 2018 Mar;144(6):780-790. doi: 10.1111/jnc.14326. J Neurochem. 2018. PMID: 29480969 Free article.

9

A tissue-based draft map of the murine MHC class I immunopeptidome.

Schuster H, Shao W, Weiss T, Pedrioli PGA, Roth P, Weller M, Campbell DS, Deutsch EW, Moritz RL, Planz O, Rammensee HG, Aebersold R, Caron E. Schuster H, et al. Among authors: weiss t. Sci Data. 2018 Aug 7;5:180157. doi: 10.1038/sdata.2018.157. Sci Data. 2018. PMID: 30084848 Free PMC article.

10

Immunocytokines are a promising immunotherapeutic approach against glioblastoma.

Weiss T, Puca E, Silginer M, Hemmerle T, Pazahr S, Bink A, Weller M, Neri D, Roth P. Weiss T, et al. Sci Transl Med. 2020 Oct 7;12(564):eabb2311. doi: 10.1126/scitranslmed.abb2311. Sci Transl Med. 2020. PMID: 33028706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,459 results

Search Page